¿Alguna vez has sentido molestias digestivas sin una causa aparente?
Esto podría deberse a un desequilibrio en la microbiota intestinal, conocido como disbiosis. Factores como el uso de antibióticos, una dieta inadecuada, el estrés y otros hábitos poco saludables pueden contribuir a este problema.
Comprender qué es la disbiosis y cómo afecta al cuerpo es clave para tomar medidas que ayuden a restaurar el equilibrio intestinal. En este artículo exploraremos sus causas, síntomas y su impacto en condiciones como el síndrome del intestino irritable (SII).
Impacto de la disbiosis en la salud
El desequilibrio en la microbiota intestinal puede tener un impacto significativo en la salud digestiva y general, y se ha asociado con diversas afecciones gastrointestinales.
Síntomas comunes
Los síntomas más frecuentes de la disbiosis incluyen:
- Digestiones pesadas
- Flatulencias
- Acidez y reflujo
- Dolor abdominal
- Estreñimiento o diarrea
Además, este desequilibrio puede aumentar la predisposición a intolerancias alimentarias, lo que lleva a la eliminación de ciertos alimentos de la dieta.
Relación con el síndrome del intestino irritable (SII)
La disbiosis puede exacerbar los síntomas del SII, como dolor abdominal, hinchazón y alteraciones en el tránsito intestinal. Los cambios en la composición bacteriana del intestino pueden incrementar la inflamación y la permeabilidad intestinal, agravando la sintomatología.
Otros problemas digestivos
Además del SII, la disbiosis puede contribuir a la malabsorción de nutrientes, lo que puede llevar a deficiencias nutricionales y afectar la salud en general. También puede desencadenar inflamación crónica del intestino, relacionada con afecciones como la enfermedad inflamatoria intestinal (EII).
Impacto en la salud general
La disbiosis no solo afecta el sistema digestivo, sino que también puede:
- Debilitar el sistema inmunológico, aumentando la susceptibilidad a infecciones.
- Contribuir a problemas dermatológicos como acné y eczema.
- Influir en el estado de ánimo y la salud mental debido a la conexión entre el intestino y el cerebro.
Cómo restaurar el equilibrio en tu intestino
Restaurar la microbiota intestinal es fundamental para mejorar la salud digestiva y general. Aquí algunas estrategias clave:
Dieta equilibrada
Una alimentación rica en fibra, frutas, verduras y alimentos fermentados es fundamental para mantener una microbiota saludable. Los alimentos con fibra prebiótica, como el ajo, la cebolla, los plátanos y los espárragos, alimentan a las bacterias beneficiosas en el intestino[1].
Hábitos saludables
Adoptar hábitos de vida saludables también es crucial para mantener una microbiota equilibrada: Hacer ejercicio de forma regular, reducir el estrés, y tener un sueño adecuado son hábitos que te ayudarán a mantener una microbiota equilibrada. [6]
Evitar el uso innecesario de antibióticos
Usar antibióticos puede alterar la flora microbiana, eliminando las bacterias dañinas y las beneficiosas. Utilízalos solo cuando sea absolutamente necesario y bajo supervisión médica [4].
La disbiosis, o el desequilibrio en la microbiota intestinal, puede tener un impacto significativo en nuestra salud digestiva y general. Sin embargo, hay muchas maneras de restaurar y mantener el equilibrio en tu intestino, como adoptar una dieta equilibrada rica en fibra y alimentos fermentados e incorporar suplementos con cepas probióticas efectivas para ayudar a mejorar la salud digestiva y fortalecer el sistema inmune.
Referencias
Probiotics: In depth. National Center for Complementary and Alternative Medicine. https://nccih.nih.gov/
health/probiotics/introduction.htm. Accessed May 7, 2018.
Khanna S, et al. A clinician's primer on the role of the microbiome in human health and disease. Mayo Clinic
Proceedings. 2014;89:107.
Dubberke ER, et al. Results from a randomized placebo-controlled clinical trial of a RBX2660-a microbiota-
based drug for the prevention of recurrent Clostridium difficile infection. Clinical Infectious Diseases. In
press. Accessed May 23, 2018.
Abdullatif VA, et al. (2021). Efficacy of probiotics as prophylaxis for urinary tract infections in premenopausal
women: A systematic review and meta-analysis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523083/
Achufusi TGO, et al. (2020). Small intestinal bacterial overgrowth: Comprehensive review of diagnosis,
prevention, and treatment methods.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386065/
Álvarez-Arraño V, et al. (2021). Effects of probiotics and synbiotics on weight loss in subjects with
overweight or obesity: A systematic review.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540110/
Asha MZ, et al. (2020). Efficacy and safety of probiotics, prebiotics and synbiotics in the treatment of
irritable bowel syndrome.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065695/
Bagherniya M. (2021). Curcumin for the treatment of prostate diseases: A systematic review of controlled
clinical trials.
https://pubmed.ncbi.nlm.nih.gov/34331700/
Bea J-M. (2018). Prophylactic efficacy of probiotics on travelers’ diarrhea: An adaptive meta-analysis of
randomized controlled trials.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232657/
Brenner DM, et al. (2009). Bifidobacterium infantis 35624: A novel probiotic for the treatment of irritable
bowel syndrome.
https://pubmed.ncbi.nlm.nih.gov/19367213/
Capurso L. (2019). Thirty years of Lactobacillus rhamnosus GG: A review.
https://pubmed.ncbi.nlm.nih.gov/30741841/
Ceccherini C, et al. (2022). Evaluating the efficacy of probiotics in IBS treatment using a systematic review
of clinical trials and multi-criteria decision analysis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268703/
Cui A, et al. (2022). Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population,
2001–2018.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573946/
Dale HF, et al. (2019). Probiotics in irritable bowel syndrome: An up-to-date systematic review.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769995/
De Souza Minayo M, et al. (2021). A systematic review of the effects of probiotics on depression and anxiety:
An alternative therapy?
https://www.scielo.br/j/csc/a/dKmhqRf3P5d9gGfHgVnPjYR/?lang=en
Dimidi E, et al. (2020). Probiotics and constipation: Mechanisms of action, evidence for effectiveness and
utilisation by patients and healthcare professionals.
https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/probiotics-and-
constipation-mechanisms-of-action-evidence-for-effectiveness-and-utilisation-by-patients-and-
healthcare-professionals/0D09EF3362228CB7C73224A123EA1FC0
Fujita K, et al. (2022). Gut microbiome and prostate cancer.
https://onlinelibrary.wiley.com/doi/10.1111/iju.14894
Guandalini S, et al. (2019). Probiotics in the treatment of inflammatory bowel disease.
https://link.springer.com/chapter/10.1007/5584_2018_319
Goodman C, et al. (2021). Probiotics for the prevention of antibiotic-associated diarrhoea: A systematic
review and meta-analysis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362734/
Haque H. (2023). Personal interview.
Iheozor-Ejiofor Z, et al. (2020). Probiotics for maintenance of remission in ulcerative colitis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059960/
Kothari D, et al. (2019). Probiotic supplements might not be universally-effective and safe: A review.
https://www.sciencedirect.com/science/article/pii/S0753332218345657?via%3Dihub
Khalesi S, et al. (2019). A review of probiotic supplementation in healthy adults: Helpful or hype?
https://pubmed.ncbi.nlm.nih.gov/29581563/
Lacy BE, et al. (2011). Pathophysiology, evaluation, and treatment of bloating.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264926/
Lerner A, et al. (2019). Probiotics: If it does not help it does not do any harm. Really?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517882/
Marinova VY, et al. (2019). Microbiological quality of probiotic dietary supplements.
https://www.tandfonline.com/doi/full/10.1080/13102818.2019.1621208
Mei Z, et al. (2022). The role of probiotics in vaginal health.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366906/
Miller LE, et al. (2019). Short-term probiotic supplementation enhances cellular immune function in healthy
elderly: systematic review and meta-analysis of controlled studies.
https://www.sciencedirect.com/science/article/pii/S0271531718307978
Mohajeri MH, et al. (2018). The role of the microbiome for human health: From basic science to clinical
applications.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962619/
Momin ES, et al. (2023). The effects of probiotics on cholesterol levels in patients with metabolic syndrome:
A systematic review.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183154/
Mourey F, et al. (2020). A multicenter, randomized, double-blind, placebo-controlled trial of Saccharomyces
boulardii in infants and children with acute diarrhea.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556239/
New FJ, et al. (2022). Role of probiotics for recurrent UT is in the twenty-first century: A systematic review
of literature.
https://link.springer.com/article/10.1007/s11934-022-01085-x
Ng QX, et al. (2018). Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females.
https://www.sciencedirect.com/science/article/abs/pii/S0306987718301208?via%3Dihub
Pais P, et al. (2020). Saccharomyces boulardii: What makes it tick as successful probiotic?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344949/
Perna S, et al. (2021). Is probiotic supplementation useful for the management of body weight and other
anthropometric measures in adults affected by overweight and obesity with metabolic related diseases? A
systematic review and meta-analysis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922558
Probiotics. (2022).
https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/
Probiotics: Usefulness and safety. (2019).
https://www.nccih.nih.gov/health/probiotics-usefulness-and-safety
Reid G, et al. (2019). Probiotics: Reiterating what they are and what they are not.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425910/
Sabaté J-M, et al. (2022). Bifidobacterium infantis 35624: A novel probiotic for the treatment of irritable
bowel syndrome.
https://pubmed.ncbi.nlm.nih.gov/35317278/
Sabaté J, et al. (2022). Effect of Bifidobacterium longum 35624 on disease severity and quality of life in
patients with irritable bowel syndrome.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891724/
Sniffen JC, et al. (2018). Choosing an appropriate probiotic product for your patient: An evidence-based
practical guide.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306248/
Sun B, et al. (2022). Bifidobacterium lactis Probio-M8 adjuvant treatment confers added benefits to patients
with coronary artery disease via target modulation of the gut-heart/-brain axes.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040731/
Sun K, et al. (2022). The effect of probiotics on the serum lipid levels in non-obese healthy adults with
hyperlipidemia: A systematic review and meta-analysis of randomized controlled trials.
https://pubmed.ncbi.nlm.nih.gov/34881632/
Tavakoly R, et al. (2021). Effect of probiotic consumption on immune response in athletes: A meta-analysis.
https://pubmed.ncbi.nlm.nih.gov/33930934/
Venema K, et al. (2019). Probiotic survival during a multi‐layered tablet development as tested in a dynamic,
computer‐controlled in vitro model of the stomach and small intestine (TIM‐1).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856813/
Vinderola G, et al. (2022). The concept of postbiotics.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027423/
Visciglia A, et al. (2022). Assessment of shelf-life and metabolic viability of a multi-strain synbiotic using
standard and innovative enumeration technologies.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672074/
Wang Z, et al. (2022). The mechanisms of the potential probiotic Lactiplantibacillus plantarum against
cardiovascular disease and the recent developments in its fermented foods.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455256/
Yakusara Z, et al. (2019). Effect of repeated consumption of partially hydrolyzed guar gum on fecal
characteristics and gut microbiota: A randomized, double-blind, placebo-controlled, and parallel-group
clinical trial.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769658/
Yang Bo, et al. (2019). A meta-analysis of the effects of probiotics and synbiotics in children with acute
diarrhea.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750275/
Yuan F, et al. (2017). Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: A
meta-analysis.
https://pubmed.ncbi.nlm.nih.gov/28166427/
Zalewska-Piątek B, et al. (2019). Phage therapy as a novel strategy in the treatment of urinary tract
infections caused by E. coli.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344395/
Zhang H, et al. (2018). Prospective study of probiotic supplementation results in immune stimulation and
improvement of upper respiratory infection rate.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995450/
